Gratus Capital LLC Pfizer Inc Transaction History

Gratus Capital LLC

  • $2.39 Billion
  • Q2 2024

A detailed history of Gratus Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Gratus Capital LLC holds 369,718 shares of PFE stock, worth $10.4 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
369,718
Previous 343,184 7.73%
Holding current value
$10.4 Million
Previous $9.52 Million 8.62%
% of portfolio
0.43%
Previous 0.45%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
BUY
$25.26 - $29.6 $670,248 - $785,406
26,534 Added 7.73%
369,718 $10.3 Million
Q1 2024

May 13, 2024
BUY
$25.89 - $29.73 $260,349 - $298,964
10,056 Added 3.02%
343,184 $9.52 Million
Q4 2023

Feb 07, 2024
SELL
$26.13 - $33.94 $218,708 - $284,077
-8,370 Reduced 2.45%
333,128 $9.59 Million
Q3 2023

Oct 26, 2023
BUY
$32.09 - $37.51 $174,537 - $204,016
5,439 Added 1.62%
341,498 $11.3 Million
Q2 2023

Aug 02, 2023
BUY
$36.12 - $41.79 $453,233 - $524,380
12,548 Added 3.88%
336,059 $12.3 Million
Q1 2023

Apr 19, 2023
SELL
$39.39 - $51.28 $51,837 - $67,484
-1,316 Reduced 0.41%
323,511 $13.2 Million
Q4 2022

Jan 27, 2023
BUY
$41.75 - $54.5 $659,232 - $860,555
15,790 Added 5.11%
324,827 $0
Q3 2022

Nov 03, 2022
BUY
$43.76 - $53.42 $1.13 Million - $1.38 Million
25,854 Added 9.13%
309,037 $13.5 Million
Q2 2022

Jul 29, 2022
BUY
$46.53 - $55.17 $505,176 - $598,980
10,857 Added 3.99%
283,183 $14.8 Million
Q1 2022

Apr 29, 2022
BUY
$45.75 - $56.69 $538,935 - $667,808
11,780 Added 4.52%
272,326 $14.1 Million
Q4 2021

Jan 31, 2022
BUY
$41.32 - $61.25 $341,385 - $506,047
8,262 Added 3.27%
260,546 $15.4 Million
Q3 2021

Nov 05, 2021
BUY
$39.25 - $50.42 $699,906 - $899,089
17,832 Added 7.61%
252,284 $10.9 Million
Q2 2021

Aug 10, 2021
BUY
$35.91 - $40.68 $707,319 - $801,273
19,697 Added 9.17%
234,452 $9.18 Million
Q1 2021

May 04, 2021
BUY
$33.49 - $37.77 $233,157 - $262,954
6,962 Added 3.35%
214,755 $7.78 Million
Q4 2020

Feb 03, 2021
BUY
$33.47 - $42.56 $280,244 - $356,354
8,373 Added 4.2%
207,793 $7.65 Million
Q3 2020

Oct 30, 2020
BUY
$31.75 - $37.25 $321,976 - $377,752
10,141 Added 5.36%
199,420 $7.32 Million
Q2 2020

Aug 11, 2020
SELL
$30.12 - $36.54 $19,096 - $23,166
-634 Reduced 0.33%
189,279 $6.19 Million
Q1 2020

May 01, 2020
BUY
$27.03 - $38.62 $4.35 Million - $6.22 Million
160,987 Added 556.55%
189,913 $6.2 Million
Q4 2019

Feb 07, 2020
BUY
$32.92 - $37.36 $131 - $149
4 Added 0.01%
28,926 $1.13 Million
Q3 2019

Oct 30, 2019
SELL
$32.49 - $42.13 $4.5 Million - $5.84 Million
-138,526 Reduced 82.73%
28,922 $1.04 Million
Q2 2019

Aug 07, 2019
BUY
$36.98 - $41.52 $82,058 - $92,132
2,219 Added 1.34%
167,448 $7.25 Million
Q1 2019

May 14, 2019
SELL
$37.5 - $41.2 $1.47 Million - $1.62 Million
-39,318 Reduced 19.22%
165,229 $7.02 Million
Q4 2018

Feb 14, 2019
SELL
$38.47 - $43.86 $294,834 - $336,143
-7,664 Reduced 3.61%
204,547 $8.93 Million
Q4 2018

Feb 13, 2019
BUY
$38.47 - $43.86 $448,983 - $511,890
11,671 Added 5.82%
212,211 $9.26 Million
Q3 2018

Nov 09, 2018
BUY
$34.47 - $41.81 $148,910 - $180,619
4,320 Added 2.2%
200,540 $8.84 Million
Q2 2018

Aug 13, 2018
SELL
$32.98 - $35.16 $37,795 - $40,293
-1,146 Reduced 0.58%
196,220 $7.12 Million
Q1 2018

May 10, 2018
SELL
$31.91 - $37.02 $648,730 - $752,616
-20,330 Reduced 9.34%
197,366 $7.01 Million
Q4 2017

Feb 07, 2018
BUY
$33.26 - $35.29 $5.75 Million - $6.1 Million
172,931 Added 386.31%
217,696 $7.89 Million
Q3 2017

Nov 09, 2017
BUY
$31.0 - $34.15 $806 - $887
26 Added 0.06%
44,765 $1.6 Million
Q2 2017

Aug 08, 2017
BUY
N/A
44,739
44,739 $1.5 Million

Others Institutions Holding PFE

# of Institutions
3,240
Shares Held
3.72B
Call Options Held
73.2M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $158B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Gratus Capital LLC Portfolio

Follow Gratus Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email